← All stories
Markets
Which part of the Poolbeg Pharma (LSE:POLB) immunotherapy story is driving UK small-cap interest today?
Highlights Poolbeg Pharma continues to feature prominently in UK junior market screens. The company is a clinical-stage business developing immunotherapy approaches in oncology. Improving AIM earnings and a gradual rate path are reshaping s…
Covered by 1 outlet
All coverage · 1 article